It’s unfortunate that the drug companies decided to end their trials early, by giving active covid vaccine to the members of the placebo group after just a few months. It means that there is no long term follow-up of the covid vaccines from randomized …
Natural infection vs vaccination: Which gives more protection?
Nearly 40% of new COVID patients were vaccinated – compared to just 1% who had been infected previously. Source: Natural infection vs vaccination: Which gives more protection?
Does it make sense to vaccinate those who have had covid?
One of the strangest things about the last few months on planet Earth has been the relentless drive to vaccinate everyone, regardless of what their individual risk from the virus is, and whether or not they’ve already had the disease. It was well…
“Proof that puts an end to the Sars-CoV-2 Narrative” | Professor Sucharit Bhakdi
Source: “Proof that puts an end to the Sars-CoV-2 Narrative” | Professor Sucharit Bhakdi
Even Mild COVID-19 Cases Can Deliver Antibody Protection For Life, Study Finds
Even a mild case of COVID-19 can create antibodies that could give you lifetime protection from the virus, according to a new study. “Months after recovering from mild cases of COVID-19, people still …
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
Abstract Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies1–7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent individuals have a significantly lower risk of reinfection8–10. Nonetheless, …
SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
The SARS-CoV-2 pandemic calls for the rapid development of diagnostic, preventive, and therapeutic approaches. CD4+ and CD8+ T cell-mediated immunity is central for control of and protection from viral infections[1-3]. A prerequisite to characterize T-cell …
Swedish Doctor: T-cell immunity and the truth about Covid-19 in Sweden
Freddie Sayers talks to Swedish doctor Soo Aleman about Covid-19.
We hear a lot about Sweden’s experience of Covid-19, with the New York Times declaring this week that that country is now “the world’s cautionary tale.”
But what’s it really like on the ground?
Dr Soo Aleman has been both on the front lines of the Covid-19 epidemic as a senior physician at Stockholm’s leading Karolinska hospital, and on the research side, as Assistant Professor at the Karolinska Institute and one of a group that last week published new data around T-cell immunity.
We talked to her about the findings of that study, and how it matches what she is seeing in her hospital.
Corona, the simple truth in under 6 minutes
This short video is a great summary of all our work we have done when it comes to so called Covid-19.
Immunity to COVID-19 is probably higher than tests have shown
Source: Immunity to COVID-19 is probably higher than tests have shown New research from Karolinska Institutet and Karolinska University Hospital shows that many people with mild or asymptomatic COVID-19 demonstrate so-called T-cell-mediated immunity …
Over half of people tested in Italy’s Bergamo have COVID-19 antibodies
More than half the residents tested in Italy’s northern province of Bergamo have COVID-19 antibodies, health authorities said on Monday, citing a sample survey. Source: Over half of people tested in Italy’s Bergamo …
Studies on Covid-19 lethality
Published: May 12, 2020; Last updated: June 12, 2020Share on: Twitter / Facebook; Main article: Facts about Covid-19 1) Covid-19 infection fatality rates (IFR) based on antibody studies Immunological research indicates that serological antibody studies, which measure antibodies in …
